# Directed Evolution of Enzymes for Bioorthogonal Chemistry Using Acid Chloride Proximity Labeling

**Authors:** Ashley N. Ogorek, Shubhashree Pani, Eli J. Mertick-Sykes, Jelena Momirov, Yichong Lao, Fernando Banales Mejia, Rachel S. T. Chan, Xuhui Huang, Bryan C. Dickinson, Jeffrey D. Martell

PMC · DOI: 10.1021/acscentsci.5c01746 · ACS Central Science · 2026-01-23

## TL;DR

Researchers developed a new method to evolve enzymes that can unmask bioorthogonal protecting groups, enabling precise control of molecular activity in cells.

## Contribution

A novel bioorthogonal protecting group (pCP) and a platform for enzyme evolution to unmask it are introduced.

## Key findings

- Evolved BS2 esterase mutants are up to 232-fold more active toward the pCP group.
- The pCP probe and evolved BS2 enabled spatially resolved RNA tagging in mammalian cells with high specificity.

## Abstract

Combining bioorthogonal protecting groups with localized
catalysts
that can unmask them is a powerful approach to spatially and temporally
modulate molecular activity. Enzymes are appealing catalysts in this
context because they are genetically targetable, but enzymes are not
always available to unmask a protecting group of interest. Here, we
report a platform for ultrahigh-throughput enzyme evolution by combining
yeast surface display with masked acylating probes, which selectively
label yeast cells based on target biocatalytic activity. We introduce
the phenylcyclopropyl (pCP) ester protecting group, which has improved
bioorthogonality compared to existing ester protecting groups, and
use our platform to evolve BS2 esterase for enhanced pCP unmasking.
Evolved BS2 mutants are up to 232-fold more active toward the pCP
group. Taking advantage of the enhanced bioorthogonality of the pCP
group, we applied a pCP probe together with evolved BS2 to perform
spatially resolved RNA tagging with high spatial specificity, including
in mammalian cell lines with high endogenous esterase activity. Overall,
this work delivers a new bioorthogonal protecting group and engineered
enzymes capable of unmasking it, and more broadly, it provides a platform
to rapidly engineer enzymes for protecting group removal, opening
opportunities in imaging, proximity tagging, induced cell signaling,
and therapeutics.

## Linked entities

- **Chemicals:** pCP (PubChem CID 192813)

## Full-text entities

- **Genes:** GAS5 (growth arrest specific 5) [NCBI Gene 60674] {aka NCRNA00030, SNHG2}, HIF1 (Hif1p) [NCBI Gene 850638], MALAT1 (metastasis associated lung adenocarcinoma transcript 1) [NCBI Gene 378938] {aka HCN, LINC00047, NCRNA00047, NEAT2, PRO2853, miPEP-52}, APEX2 (apurinic/apyrimidinic endodeoxyribonuclease 2) [NCBI Gene 27301] {aka APE2, APEXL2, XTH2, ZGRF2}, IBA57 (Iba57p) [NCBI Gene 853586] {aka CAF17}, SNHG12 (small nucleolar RNA host gene 12) [NCBI Gene 85028] {aka ASLNC04080, C1orf79, LINC00100, LINC001000, NCRNA00100, PNAS-123}, SAV1 (salvador family WW domain containing protein 1) [NCBI Gene 60485] {aka SAV, WW45, WWP4}, NEAT1 (nuclear paraspeckle assembly transcript 1) [NCBI Gene 283131] {aka LINC00084, NCRNA00084, TP53LC15, TncRNA, VINC}, PSMG2 (proteasome assembly chaperone 2) [NCBI Gene 56984] {aka CLAST3, HCCA3, HsT1707, MDS003, PAC2, PRAAS4}, PHB2 (prohibitin 2) [NCBI Gene 11331] {aka BAP, BCAP37, Bap37, PNAS-141, REA, hBAP}
- **Diseases:** tumor (MESH:D009369), TNBC (MESH:D064726), breast cancer (MESH:D001943), toxicity (MESH:D064420)
- **Chemicals:** copper (MESH:D003300), biotin (MESH:D001710), NaOH (MESH:D012972), aniline (MESH:C023650), tyrosine (MESH:D014443), water (MESH:D014867), FL (MESH:D005459), coumarin (MESH:C030123), azide (MESH:D001386), polymer (MESH:D011108), ester (MESH:D004952), metal (MESH:D008670), Acid (MESH:D000143), PBS (MESH:D007854), alkyne (MESH:D000480), polyA (MESH:D011061), para-nitrophenyl butyrate (MESH:C033592), DAPI (MESH:C007293), glutathione (MESH:D005978), phenoxy radicals (MESH:C042329), fluorescein (MESH:D019793), AlexaFluor488 (MESH:C000711379), amines (MESH:D000588), 7-hydroxycoumarin (MESH:C031477), bis-caged AM ester fluorescein (-)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** M212 V, K209R, A328T, T1A, P287L, L361, M220P, F397S, L361F, I470V, Y108H, D319A, M220L/K, S153P, M220L, K481E, Q271R
- **Cell lines:** AC-2 — Mus musculus (Mouse), Factor-dependent cell line (CVCL_4102), HEK293T — Homo sapiens (Human), Transformed cell line (CVCL_0063), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), MDA-MD-453 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0418), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947558/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12947558/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947558/full.md

---
Source: https://tomesphere.com/paper/PMC12947558